CYSLTR1 and schistosomiasis: The present study aimed to investigate the role of cysLTR1 during experimental acute and chronic schistosomiasis using cysLTR1<sup>-/-</sup> mice, as well as the use of cysLTR1 inhibitor (Montelukast) to assess immune responses during chronic <i>Schistosoma mansoni</i> infection.